Professional Documents
Culture Documents
DHF2
DHF2
Rekomendasi :
Cairan kristaloid NaCl 5-10 ml/kg/jam karena
pasien mengalami penurunan Natrium dan
mendapat transfusi PRC.
Daftar Pustaka
Acharya, C. A., & Bajaj, J. S. (2015). Covert and overt hepatic encephalopathy: current options for diagnosis and
treatment. Current Hepatology Reports, 14(3), 234-242.
Depkes RI, 2007, Pharmaceutical care Untuk Penyakit Hati, Jakarta: Departemen Kesehatan RI.
KDOQI, 2002, Clinical Practice Guidelines for Chronic Kidney Disease: Evaluasi, Clasification and Stratification,
National Kidney Foundation, New York
Leise, M. D., Poterucha, J. J., Kamath, P. S., & Kim, W. R. (2014, February). Management of hepatic encephalopathy in
the hospital. In Mayo Clinic Proceedings (Vol. 89, No. 2, pp. 241-253). Elsevier.
NKF, 2016, Best Practice in Managing Hyperkalemia in Chronic Kidney Foundation, New York.
Pani, et al., 2014, Hyperkalemia in Hemodialysis Patients, Clinical Consequences of Hyperkalemia, 27 (6) : 571-576
Rose, C. F. (2012). Ammonia‐lowering strategies for the treatment of hepatic encephalopathy. Clinical Pharmacology &
Therapeutics, 92(3), 321-331.
Tiuca N, Sztogrin W, 2011, The News of Treatment of Variceal Upper Gastrointestinal Bleeding, Journal of Medicine and
Life Vol. 4, Issue 4, October‐December 2011, pp.395‐398
Vilstrup, H., Amodio, P., Bajaj, J., Ferenci, P., Mullen, K. D., Weissenborn, K., dan Merriman, R. B. (2014). Hepatic
encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the
Liver and the American Association for the Study of Liver Diseases. Journal of hepatology, 61(3), 642-659.